Keyword Analysis & Research: sb203580


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
sb20358020.29105728

Keyword Research: People who searched sb203580 also searched

Keyword CPC PCC Volume Score
sb2035800.970.670724

Search Results related to sb203580 on Search Engine

  • Pharmacological profile of SB 203580, a selective inhibitor of …

    aspetjournals.org

    https://jpet.aspetjournals.org/content/279/3/1453

    WebDec 1, 1996 · Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. | Journal of Pharmacology and Experimental Therapeutics. Abstract.

    DA: 24 PA: 36 MOZ Rank: 53

  • Medical Countermeasures

    medicalcountermeasures.gov

    https://www.medicalcountermeasures.gov/newsroom/2020/sab-185/

    WebApr 1, 2020 · Therapeutics are urgently needed to treat the symptoms of COVID-19, especially in the absence of vaccines to help control the spread of the disease. BARDA is working with its partners across industry and government to build a portfolio of medical countermeasures, including drugs, vaccines and diagnostic tests, for this COVID-19 …

    DA: 42 PA: 48 MOZ Rank: 15

  • PubMed

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/9786874/

    WebThe CCK-B/gastrin receptor (CCK-BR) mediates the effects of gastrin on gastric acid secretion and mucosal growth. This study investigates the molecular basis of the species differences in CCK-BR expression and function, and …

    DA: 31 PA: 48 MOZ Rank: 59

  • SB203580 | Cell Signaling Technology

    cellsignal.com

    https://www.cellsignal.com/products/activators-inhibitors/sb203580/5633

    WebSB203580 (4- (4-fluorophenyl)-2- (4-methylsulfinylphenyl)-5- (4-pyridyl)-imidazole) is a selective inhibitor of p38 MAPK. This compound inhibits the activation of MAPKAPK-2 by p38 MAPK and subsequent phosphorylation of HSP27 (9).

    DA: 99 PA: 16 MOZ Rank: 29

  • SB203580: Akt & p38 MAP Kinases Inhibitor | InvivoGen

    invivogen.com

    https://www.invivogen.com/sb203580

    WebSB203580 is a pyridinyl imidazole inhibitor widely used to study the role of p38 mitogen-activated protein (MAP) kinase [1]. The p38 MAP kinase signaling pathway allows cells to interpret a wide range of external signals and respond appropriately by generating a plethora of different biological effects. More details.

    DA: 18 PA: 49 MOZ Rank: 57


  • Unexpected inhibition of the lipid kinase PIKfyve reveals an

    nature.com

    https://www.nature.com/articles/s41419-024-06423-0

    WebJan 22, 2024 · Herein, we report that SB203580-induced vacuolation is rapid, reversible, and relies on the class III phosphatidylinositol 3-kinase (PIK3C3) complex and the production of phosphatidylinositol...

    DA: 52 PA: 5 MOZ Rank: 66

  • SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657816/

    WebNov 26, 2021 · PMCID: PMC8657816. PMID: 34884593. SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma. Milena Paw, * Dawid Wnuk, Kinga Nit, Sylwia Bobis-Wozowicz, Rafał Szychowski, Alicja Ślusarczyk, Zbigniew Madeja, and Marta Michalik.

    DA: 43 PA: 69 MOZ Rank: 83

  • SB203580, a p38 mitogen-activated protein kinase inhibitor

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/20956267/

    WebResults: SB203580 decreased the weight and size (P < 0.05 versus EM) of endometriotic lesions in BALB/c mice. IL-1β, TNF-α, MMP-2 and MMP-9 mRNA levels were decreased in peritoneal cells of the SB203580 versus EM group (P < 0.01, P < 0.05, P < 0.05 and P < 0.05, respectively).

    DA: 52 PA: 40 MOZ Rank: 40

  • Differential effects of p38 MAP kinase inhibitors SB203580 and …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507849/

    WebApr 9, 2017 · On the other hand, SB203580 inhibits p38 MAPK catalytic activity by binding to the ATP-binding pocket but does not inhibit phosphorylation of p38 MAPK by upstream kinases (Kumar et al. 1999). Both SB202190 and SB203580 are known to be specific inhibitors of p38α and p38β isoforms (Nemoto et al. 1998; Sicard et al. 2010). First, we …

    DA: 28 PA: 7 MOZ Rank: 26

  • SB203580 | Data sheet | InvivoGen

    invivogen.com

    https://www.invivogen.com/sites/default/files/invivogen/products/files/sb203580_tds.pdf

    WebSB203580 is a pyridinyl imidazole inhibitor widely used to study the role of p38 mitogen-activated protein kinase (MAPK)1. p38 MAPKs are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are involved in cell differentiation, apoptosis, and autophagy.

    DA: 7 PA: 38 MOZ Rank: 51